Thyrocare Technologies added 2.70% to Rs 838.30 after the healthcare service provider reported 28.56% increase in consolidated net profit to Rs 18.95 crore on 23.14% rise in revenue from operations to ...

Shriram Finance is expected to post an 18 percent year-on-year (YoY) growth in loans for Q3FY25, with sequential growth ...

IST, the barometer index, the S&P BSE Sensex shed 26.18 points or 0.03% to 76,494.20. The Nifty 50 index lost 21.60 points or 0.09% to 23,183.75.

Dr. Reddy’s Laboratories shares fell by 6.2%, hitting an intraday low of Rs 1,209.70 on the BSE on Friday, January 24, following the release of its Q3 FY25 earnings report. The pharma major posted a ...

Shares of Dr Reddy's Laboratories Ltd tumbled more than 6.65 per cent to Rs 1,203.60 on Friday, with its total market capitalisation slipping below Rs 1 lakh crore mark.

The stock slumped 9 per cent to hit a low of Rs 994.05 over its previous close of Rs 1096.75. Market cap of the Tata Group ...

Indian benchmark indices faced losses led by PSU banks and pharma stocks, while Power Grid and ICICI Bank gained. Wall Street ...

Cyient is grappling with multiple challenges, including disappointing Q3 results, a downward revision in FY25 growth guidance, and the CEO's resignation, all of which have dampened investor sentiment.

Today, majors including DLF, Interglobe Aviation, Godrej Consumer Products, NIIT, DCB Bank, Bank of India, others are ...

Torrent Pharma, IndiGo parent InterGlobe Aviation, Godrej Consumer Products, JSW Steel, and Bank of India are among few of the key firms that will report Q3 results today. Track updates here ...

Dr Reddy’s shares tumbled up to 6% in early trade and at 9:46 am, they were trading 4.35% lower at Rs 1,233.25 on the Bombay Stock Exchange (BSE).